Acta Paediatrica · 2003 · 42 citations · 26 references
MedicineInfectious DiseasesPediatricsBone MetabolismPediatric ImmunologyVirologyBone DevelopmentBone DisordersBone GrowthBone HealthBone Metabolism DisordersMetabolic Bone DiseaseBone DensitometryBone Mass GainBone Mineral DensityBone Mineral Density DeclineBone Mineral LossDual-energy X-ray Absorptiometry AssessmentInsulin-like Growth FactorsViral Load Assessment
AIM: Data on bone homoeostasis of children infected with human immunodeficiency virus (HIV), at the time of the gain in bone mass, are very rare. To determine possible alterations in bone metabolism, 13 prepubertal vertically HIV-infected children were studied. METHODS: Viral load, CD4 count, interleukin-6 (IL-6), growth hormone, insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), acid-labile subunit (ALS), IGFBP-3 proteolysis, osteocalcin in blood and N-terminal telopeptide of type I collagen in urine were determined. Lumbar spine bone mineral density was examined by dual-energy X-ray absorptiometry. RESULTS: Low osteocalcin levels were found in all patients. Low IGF-I was found in only six children, who had low CD4 count and high IL-6 levels, with normal levels of IGFBP-3 and ALS, absent IGFBP-3 proteolysis and decreased bone mineral density, irrespective of viral load or growth. CONCLUSION: Low serum osteocalcin levels appear to be an initial warning sign of possible altered bone metabolism in HIV-infected children. However, only when the immune system becomes more seriously compromised is bone loss measurable by bone densitometry.
26
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
Pablo Tebas, William G. Powderly, Sherry Claxton et al. · AIDS · 2000 · 541 citations